Session Date/Location:
Monday, May 7, 2012, 9a3-12pm
Room 121B, Level 1, Pennsylvania Convention Center
Psychiatrists and Pharma: How Should They Interact? (workshop 75)
Chair & Presenter: Paul S. Appelbaum, MD, the Elizabeth K. Dollard Professor of Psychiatry, Medicine and Law, and director, Division of Law, Ethics and Psychiatry at Columbia University Medical Center and the New York State Psychiatric Institute. Dr. Appelbaum is past-president of the APA, where he currently serves as chair of APA's Committee on Judicial Action. He is an elected member of the Institute of Medicine of the National Academy of Sciences.
About the Session: Controversy continues over the extent to which psychiatrists' relationships with pharmaceutical companies may compromise their roles as clinicians, educators and researchers. In 2011, the World Psychiatric Association adopted a set of recommendations (which Dr. Appelbaum helped draft) for interactions of psychiatrists and their organizations with the pharmaceutical industry. The guidelines address interactions affecting patient care, education and research, along with issues specific to professional associations. Using the WPA recommendations as a starting point, the workshop will explore the ethical principles that should underlie such relationships and how they might be applied in practice.
Session Date/Location:
Monday, May 7, 2012, 11am-12:30pm
Room 110B, Level 1, Pennsylvania Convention Cen
'/>"/>
| Contact: Rachel Yarmolinsky ry2134@columbia.edu 212-543-5353 Columbia University Medical Center Source:Eurekalert |